Teva’s Bold Climate Goals Confirmed: SBTi Validates Ambitious Targets

Teva Pharmaceuticals Industries Ltd is proud to have its targets to reduce greenhouse gas (GHG) emissions approved by the Science Based Targets initiative (SBTi), demonstrating its commitment to minimizing its environmental footprint. This external validation is a testament to the Company’s ambitious and inspiring goals to help combat climate change.

As one of the largest manufacturers of generic medicines in the world, Teva is dedicated to making treatments more accessible and affordable for its patients. With a presence in almost 200 countries, the Company is committed to reducing its carbon footprint and making a positive impact on the environment. By providing quality treatments to millions of patients every day, Teva is making a lasting difference in the world.

By 2030, we are committed to reducing our absolute scope 1 and 2 GHG emissions by 46%, in line with a 1.5°C pathway, and our absolute scope 3 GHG emissions by 25%, in line with a well-below 2°C pathway. This has been validated by the Science Based Targets initiative and is a positive step in the fight against climate change.

In an unprecedented move, Teva unveiled a sustainability-linked bond worth $5 billion – the largest of its kind from any sector – as part of its financing strategy, integrating Scope 1 and 2 targets. This marked the first sustainability-linked bond issued by a generic medicines company.

At Teva, we recognize that the health of our planet is vital to the health of its inhabitants. That’s why we are proud to have our ambitious targets validated by the Science Based Targets Initiative (SBTi) for their alignment with global goals to combat climate change. Our commitment to promoting a healthier and more sustainable future is one we take seriously, and SBTi’s validation is further proof of our dedication. Amalia Adler-Waxman, Senior Vice President, Global Head, ESG and Head of Corporate Affairs of International Markets at Teva, says it best, “Health is what we do at Teva.”

Teva is committed to protecting the environment and is making strides to ensure the success of its environmental, social and governance (ESG) strategy. This includes converting some manufacturing sites to renewable electricity, introducing low-carbon truck fleets and electric vehicles, and recycling water. Teva is also taking steps to make office catering and canteen services more sustainable, all of which are part of the Company’s culture and demonstrate its dedication to creating a greener future.

Teva is committed to upholding its environmental targets, and will be regularly reporting on their progress and having their performance externally verified in the Company’s annual ESG Progress Report. Stay tuned for updates and feel confident that Teva is taking the necessary steps to ensure environmental sustainability!

About Teva

For more than a hundred years, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been dedicated to making life better for millions of people worldwide. We have an extensive portfolio of over 3,500 generic, biosimilar, and innovative medicines in every therapeutic area, and our medicines are taken by an astonishing 200 million people every day. We are a leader in the pharmaceutical industry, with a highly complex and extensive supply chain, as well as a rapidly growing portfolio of innovative medicines and biopharmaceutical products. Our commitment to improving lives has never been stronger.

Leave a Comment